Literature DB >> 26587927

Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.

Andrew B Rosenkrantz1, Justin M Ream1, Paul Nolan1, Henry Rusinek1, Fang-Ming Deng2, Samir S Taneja3.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the additional value of whole-lesion histogram apparent diffusion coefficient (ADC) metrics, when combined with standard pathologic features, in prediction of biochemical recurrence (BCR) after radical prostatectomy for prostate cancer.
MATERIALS AND METHODS: The study included 193 patients (mean age, 61 ± 7 years) who underwent 3-T MRI with DWI (b values, 50 and 1000 s/mm(2)) before prostatectomy. Histogram metrics were derived from 3D volumes of interest encompassing the entire lesion on ADC maps. Pathologic features from radical prostatectomy and subsequent BCR were recorded for each patient. The Fisher exact test and Mann-Whitney test were used to compare ADC-based metrics and pathologic features between patients with and patients without BCR. Stepwise logistic regression analysis was used to construct multivariable models for prediction of BCR, which were assessed by ROC analysis.
RESULTS: BCR occurred in 16.6% (32/193) of patients. Variables significantly associated with BCR included primary Gleason grade, Gleason score, extraprostatic extension, seminal vesicle invasion, positive surgical margin, preoperative prostate-specific antigen level, MRI tumor volume, mean whole-lesion ADC, entropy ADC, and mean ADC of the bottom 10th, 10-25th, and 25-50th percentiles (p ≤ 0.019). Significant independent predictors of BCR at multivariable analysis were primary Gleason grade, extraprostatic extension, mean of the bottom 10th percentile ADC, and entropy ADC (p = 0.002-0.037). The AUC of this multivariable model was 0.94 for prediction of BCR; the AUC of pathologic features alone was 0.89 (p = 0.001).
CONCLUSION: A model integrating whole-lesion ADC metrics had significantly higher performance for prediction of BCR than did standard pathologic features alone and may help guide postoperative prognostic assessments and decisions regarding adjuvant therapy.

Entities:  

Keywords:  DWI; MRI; apparent diffusion coefficient; prostate cancer; radical prostatectomy

Mesh:

Substances:

Year:  2015        PMID: 26587927      PMCID: PMC4691847          DOI: 10.2214/AJR.15.14482

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  32 in total

Review 1.  pT0 prostate cancer after radical prostatectomy.

Authors:  Jenna L Gross; Timothy A Masterson; Liang Cheng; Peter A S Johnstone
Journal:  J Surg Oncol       Date:  2010-09-15       Impact factor: 3.454

2.  Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.

Authors:  Andrew J Stephenson; Alex Smith; Michael W Kattan; Jaya Satagopan; Victor E Reuter; Peter T Scardino; William L Gerald
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

3.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

4.  Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Christopher J DiBlasio; Alwyn Reuther; Eric A Klein; Michael W Kattan
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

5.  Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.

Authors:  Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario Eisenberger; Alan W Partin
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

Review 6.  An updated catalog of prostate cancer predictive tools.

Authors:  Shahrokh F Shariat; Pierre I Karakiewicz; Claus G Roehrborn; Michael W Kattan
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

7.  Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.

Authors:  Jochen Walz; Felix K-H Chun; Eric A Klein; Alwyn Reuther; Fred Saad; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Journal:  J Urol       Date:  2008-12-13       Impact factor: 7.450

8.  Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.

Authors:  Michael H Fuchsjäger; Amita Shukla-Dave; Hedvig Hricak; Liang Wang; Karim Touijer; John F Donohue; James A Eastham; Michael W Kattan
Journal:  BJU Int       Date:  2009-02-11       Impact factor: 5.588

9.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.

Authors:  Deanna L Langer; Theodorus H van der Kwast; Andrew J Evans; Laibao Sun; Martin J Yaffe; John Trachtenberg; Masoom A Haider
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

10.  Comparison of models to predict clinical failure after radical prostatectomy.

Authors:  Scott E Eggener; Andrew J Vickers; Angel M Serio; Michael J Donovan; Faisal M Khan; Valentina Bayer-Zubek; David Verbel; Carlos Cordon-Cardo; Victor E Reuter; Fernando J Bianco; Peter T Scardino
Journal:  Cancer       Date:  2009-01-15       Impact factor: 6.860

View more
  12 in total

Review 1.  Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.

Authors:  Matthew J Watson; Arvin K George; Mahir Maruf; Thomas P Frye; Akhil Muthigi; Michael Kongnyuy; Subin G Valayil; Peter A Pinto
Journal:  Future Oncol       Date:  2016-07-12       Impact factor: 3.404

2.  Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.

Authors:  Nelly Tan; Luyao Shen; Pooria Khoshnoodi; Héctor E Alcalá; Weixia Yu; William Hsu; Robert E Reiter; David Y Lu; Steven S Raman
Journal:  J Urol       Date:  2017-11-08       Impact factor: 7.450

Review 3.  Background, current role, and potential applications of radiogenomics.

Authors:  Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris
Journal:  J Magn Reson Imaging       Date:  2017-11-02       Impact factor: 4.813

Review 4.  Diffusion-weighted imaging in prostate cancer.

Authors:  Tsutomu Tamada; Yu Ueda; Yoshiko Ueno; Yuichi Kojima; Ayumu Kido; Akira Yamamoto
Journal:  MAGMA       Date:  2021-09-07       Impact factor: 2.533

5.  Detection of prostate cancer local recurrence following radical prostatectomy: assessment using a continuously acquired radial golden-angle compressed sensing acquisition.

Authors:  Andrew B Rosenkrantz; Anunita Khasgiwala; Ankur M Doshi; Justin M Ream; Samir S Taneja; Herbert Lepor
Journal:  Abdom Radiol (NY)       Date:  2017-01

Review 6.  Prostate cancer risk stratification with magnetic resonance imaging.

Authors:  Ely R Felker; Daniel J Margolis; Nima Nassiri; Leonard S Marks
Journal:  Urol Oncol       Date:  2016-03-31       Impact factor: 3.498

7.  Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.

Authors:  Stephanie A Harmon; William Gesztes; Denise Young; Sherif Mehralivand; Yolanda McKinney; Thomas Sanford; Jonathan Sackett; Jennifer Cullen; Inger L Rosner; Shiv Srivastava; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Albert Dobi; Isabell A Sesterhenn; Baris Turkbey
Journal:  Radiology       Date:  2021-04-13       Impact factor: 29.146

8.  Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.

Authors:  Jie Meng; Lijing Zhu; Li Zhu; Huanhuan Wang; Song Liu; Jing Yan; Baorui Liu; Yue Guan; Yun Ge; Jian He; Zhengyang Zhou; Xiaofeng Yang
Journal:  Radiat Oncol       Date:  2016-10-22       Impact factor: 3.481

Review 9.  Combining molecular and imaging metrics in cancer: radiogenomics.

Authors:  Roberto Lo Gullo; Isaac Daimiel; Elizabeth A Morris; Katja Pinker
Journal:  Insights Imaging       Date:  2020-01-03

10.  Effects of Echo Time on IVIM Quantification of the Normal Prostate.

Authors:  Zhaoyan Feng; Xiangde Min; Liang Wang; Xu Yan; Basen Li; Zan Ke; Peipei Zhang; Huijuan You
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.